Dr. Marina Murphy is Senior Director of Scientific Affairs at Haypp Group, where she leads scientific communications and public health advocacy to support tobacco harm reduction. With over 20 years’ experience, she has held senior roles at Juul Labs, British American Tobacco, and ANDS, focusing on translating complex science into accessible, evidence-based narratives. Marina is a passionate advocate for transparent science communication and sound regulatory frameworks that support public health. A vocal proponent of evidence-based policy, she regularly addresses misinformation around nicotine products.
Marina holds a Ph.D. in chemistry from the National University of Ireland, Galway and a Masters in Science Communication for Dublin City University, Ireland.
Ross Henry Law is a reporter for GlobalData’s healthcare publications. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer’s disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
Few people with a cause walk the talk as boldly and graciously as Christine Von Raesfeld, Lived Experience Expert/Citizen Scientist. Christine is a pillar of patient advocacy and allyship in the rare and chronic disease community. Through the lens of her own journey in healthcare, she has become a champion for patient voices, diversity and inclusion in clinical research, and equitable patient-sponsor partnerships.**
A sought-after speaker, Christine brings firsthand expertise to discussions on clinical trials, data rights, and digital health. She serves as an e-patient scholar with Stanford MedicineX and a Committee Member with the Partnership for Quality Measures (CMS), among other roles. Christine advises initiatives like Stanford’s “Humanwide” Precision Medicine Program, the NIH All of Us Research Program, and the NIH HEAL Initiative. She co-authored the patient-led AI Rights Initiative with The Light Collective, focusing on ethical data use and personalized medicine.
Christine recently published a research paper analyzing her own complex medical journey[43dcd9a7-70db-4a1f-b0ae-981daa162054](https://journal.researchtothepeople.org/christine?citationMarker=43dcd9a7-70db-4a1f-b0ae-981daa162054 “1”), highlighting the value of patient-partnered genomics in understanding rare and chronic conditions. She has additional works on patient engagement and healthcare innovation forthcoming.
Recognized for her contributions, she has been named one of Silicon Valley Business Journal’s Top 100 Women of Influence, a Silicon Valley Community Hero, a member of the 2021 HIMSS Future50, and one of Medika Life’s 50 most influential voices in healthcare.
